Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1178 of 6351
-
Heart attack diagnosis revolution? new method could save lives
Diagnosis OngoingThe investigators hypothesize that occlusion myocardial infarction(MI)/non-occlusion MI approach to MI treatment will better predict acute coronary occlusion on coronary angiography, better limit infarct size, better preserve left ventricular function and result in lower long-ter…
Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 13:02 UTC
-
Could everyday disinfectants be harming us? a new study investigates
Knowledge-focused OngoingResearch Purpose and Significance: Quaternary ammonium compounds (QACs), as cationic surfactants, are widely used in disinfectants, cosmetics, fabric softeners, hair conditioners, and other personal care products. They are a class of emerging organic pollutants commonly found in…
Early phase 1 • Sponsor: National Natural Science Foundation of China • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
New psoriasis drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study is a randomized, double-blind phase 2 clinical trial aimed at exploring the efficacy, safety, and immunogenicity of HB0017 injection with different dosing regimens in the treatment of moderate to severe plaque psoriasis in subjects
Phase 2 • Sponsor: Huabo Biopharm Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC
-
Blood test aims to unmask hidden TB infections before they turn deadly
Knowledge-focused By invitation onlyMycobacterium tuberculosis (Mtb) is a major human pathogen, responsible for an estimated 10.6 million cases of active tuberculosis (TB) and 1.6 million deaths in 2021. Most adult cases of active TB arise from progression of latent tuberculosis infection (LTBI), whose global preva…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New cholesterol drugs show promise in Late-Stage trial
Disease control CompletedA Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R in Patients with Primary Hypercholesterolemia
Phase 3 • Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Parkinson's psychosis drug shows promise in final trial
Symptom relief CompletedThe purpose of this study is to evaluate the safety and efficacy of 34 mg pimavanserin compared to placebo in patients with Parkinson's disease psychosis (PDP).
Phase 3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Pedaling past paralysis: cycling therapy shows promise for stroke survivors
Symptom relief Recruiting nowTraditional rehabilitation approaches are time and personnel intensive and costly, and leave \~75% of stroke survivors with residual disability. We propose a clinical trial to determine effects of forced aerobic exercise (FE; i.e., mechanically supplemented) in facilitating upper…
Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Could cochlear implants help more people hear? new study expands eligibility.
Symptom relief OngoingThis study aims to evaluate the safety and efficacy of cochlear implantation for adults with bilateral sensorineural hearing loss who currently do not meet the FDA-approved indications for cochlear implantation. Following cochlear implantation, participants will complete speech p…
Sponsor: Cochlear • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Experimental virus therapy takes on advanced cancers in first human trial
Disease control Recruiting nowVET3-TGI is an oncolytic immunotherapy designed to treat advanced cancers. VET3-TGI has not been given to human patients yet, and the current study is designed to find a safe and effective dose of VET3-TGI when administered by direct injection into tumor(s) (called an intratumora…
Phase 1 • Sponsor: KaliVir Immunotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a daily pill keep the weight off after stopping injectables?
Disease control CompletedThe main purpose of this study is to evaluate the efficacy and safety of orforglipron on maintenance of body weight reduction in participants who previously completed treatment with injectable tirzepatide (Zepbound) or injectable semaglutide (Wegovy) in the SURMOUNT-5 trial (NCT0…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could CAR-T cells tame autoimmune diseases? early trial begins
Disease control PausedThis is an open-label, investigator-initiated clinical trial (IIT) aimed at evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-04 in patients with active SLE, SSc, AAV, IIM, and pSS
Early phase 1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Cheaper keytruda clone tested for early lung cancer
Disease control OngoingThe primary objective of this study is to demonstrate pharmacokinetic (PK) similarity ABP 234 with pembrolizumab.
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo shot targets stomach cancer belly fluid
Disease control Recruiting nowThis study is to evaluate the safety and efficacy of intraperitoneal injection of immune checkpoint inhibitor combined with zoledronic acid for the treatment of malignant ascites in gastric cancer. This study is a phase Ib/II clinical study to evaluate the safety and efficacy of…
Phase 1/2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a simple Self-Swap replace the speculum for cervical cancer screening?
Diagnosis OngoingThis clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve cervical cancer prevention. HPV is a common virus which usually causes infections …
Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Oral chemotherapy pill tested for advanced breast cancer
Disease control OngoingThis study looks at how well oral vinorelbine works in treating advanced breast cancer. It looks at women who have already had this treatment or are currently having it.
Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New bladder cancer combo aims to help patients who Can't take chemo
Disease control Recruiting nowSTAR-EV will evaluate the combination of enfortumab vedotin plus radiotherapy (RT) as neoadjuvant treatment for muscle invasive bladder cancer prior to radical cystectomy surgery. The study will use "dose escalation" to evaluate the safety and efficacy of study treatment at three…
Phase 1/2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 26, 2026 17:25 UTC
-
New biologic IBI311 shows promise for thyroid eye disease in early trial
Disease control CompletedThis is a multicenter, randomized, double-masked phase II study evaluating the efficacy and safety of IBI311 in subjects with inactive or active thyroid eye disease. Approximately 36 subjects meeting the study eligibility criteria will be randomly assigned to the 3-10 mg group, 3…
Phase 2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New placental patch shows promise for diabetic foot ulcers
Disease control CompletedThis trial is a multicenter, randomized, controlled study designed to evaluate the safety and efficacy of BioREtain® Amnion Chorion (BR-AC) plus standard of care versus standard of care only in the treatment of diabetic foot ulcers. The trial design will control potential variabl…
Sponsor: BioStem Technologies • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New daily pill shows promise for rheumatoid arthritis in early trial
Disease control CompletedThe goal of this multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial is to evaluate the efficacy and safety of proximod in active rheumatoid arthritis patients with inadequate response or intolerance to conventional synthetic disease-modifying antirhe…
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can a national biobank network end the diagnostic odyssey for rare diseases?
Knowledge-focused Recruiting nowRare diseases (RDs) have been defined by the European Union (EU) as life-threatening or chronically debilitating conditions affecting less than 1 person in 2000. RDs are complex and often need special treatments, thus combined efforts are required to address them to improve diagn…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC